Smart contact lens tests pressure, delivery
- Yangzhi Zhu’s team at the Terasaki Institute reported an all-polymer smart contact lens in *Science Translational Medicine* on April 8 that monitors eye pressure and releases glaucoma drugs in preclinical tests. - The battery-free lens used pressure-gated microchannels to deliver timolol or brimonidine when intraocular pressure crossed preset thresholds, with rabbit and bovine-eye tests tracking closely against standard tonometry. - The work targets a disease projected to reach about 134 million cases worldwide by 2040 and aims to reduce missed daily drops and snapshot clinic measurements. (science.org)
Glaucoma care usually depends on two imperfect tools: pressure checks taken during office visits and eye drops patients have to remember every day. (science.org) (statnews.com) A paper published April 8 in *Science Translational Medicine* describes a soft smart contact lens designed to do both jobs at once. Yangzhi Zhu and colleagues reported a battery-free, all-polymer lens that senses intraocular pressure and releases medicine when pressure rises past preset levels. (science.org) (terasaki.org) In plain terms, the lens works like a tiny flexible hydraulic switch. When pressure inside the eye changes, the cornea and the lens deform slightly, shifting fluid through embedded microchannels that both register the change and open staged drug reservoirs. (science.org) (statnews.com) The drugs tested were timolol and brimonidine, two standard glaucoma medicines. The paper says the lens triggered delivery only above programmed pressure thresholds and lowered pressure in rabbit ocular-hypertension models to levels comparable with conventional topical therapy. (science.org) The researchers tested the system in three steps: an artificial eye model, removed bovine eyes, and live rabbits with elevated eye pressure. Across those settings, the pressure readings aligned with tonometry, the standard clinic method for measuring intraocular pressure. (science.org) One reason engineers keep chasing continuous pressure sensing is that glaucoma pressure is not static. The paper notes that office-based applanation tonometry captures only snapshots, even though intraocular pressure changes through the day and can shape treatment decisions. (science.org) (statnews.com) Another problem is adherence. STAT reported that daily eye-drop use often slips over time, and Zhu’s group framed the lens as a way to combine monitoring and treatment in one wearable device rather than relying on repeated manual dosing. (statnews.com) (terasaki.org) This is not the first smart lens aimed at glaucoma, but earlier systems often used electronics, batteries, or bulkier hardware. The new paper positions its all-polymer design as a comfort and safety play, with no rigid electronic components sitting on the eye. (science.org) (nature.com) The study is still preclinical, not a human efficacy trial. The authors say the results support clinical translation, but the evidence so far comes from laboratory models, bovine eyes, and rabbits rather than patients wearing the lens in routine care. (science.org) (terasaki.org) That leaves the lens in a familiar place for medical devices: promising on the bench, unproven in the clinic. But for a disease the paper says could affect about 134 million people worldwide by 2040, the pitch is straightforward — measure pressure continuously, and treat it without waiting for the next missed drop. (science.org)
